Full-Time
Ultrasound Technologist 1
PRN
Updated on 9/4/2026
West Cancer Center
51-200 employees
Provides cancer care with clinical trials
No salary listed
Germantown, TN, USA
In Person
 Medical, Clinical & Veterinary (1) |
|---|
Get referred to West Cancer Center
See people who can refer or advise you
- Completion of one of the educational prerequisites outlined in the American Registry for Diagnostic Medical Sonography examination guidelines.
- Zero to one year of Ultrasound Technologist experience.
- Certification and registration as a Diagnostic Medical Sonographer through the American Registry for Diagnostic Medical Sonography in Breast.
- Must obtain American Registry for Diagnostic Medical Sonography certification and registration within twelve months of hire.
- Basic Life Support certification through the American Heart Association.
- Skill in performing ultrasound examinations in designated specialty areas.
- Ability to understand and prepare complex written materials, including patient records and technical manuals.
- Ability to communicate effectively with physicians, patients, families, and coworkers.
- Ability to work independently and exercise sound judgment.
- Ability to organize multiple tasks and maintain effective workflow management.
- Frequent invasive and non-invasive patient contact.
- Exposure to patient body fluids as well as hazardous or poisonous materials.
- Ability to react quickly in emergency situations.
- Medium work requiring exertion of up to 50 pounds occasionally and/or up to 25 pounds frequently.
- Frequent standing, walking, reaching, grasping, kneeling, stooping, and repetitive motion.
- Must have good balance, coordination, and hand-eye coordination.
- Requires close visual acuity, including color vision, depth perception, and field of vision.
- Perform ultrasound examinations in accordance with Radiology and Breast Center ultrasound procedure protocols.
- Provide ongoing patient assessment through observation and review of patient records, reporting findings accurately and promptly.
- Assist in the development of others through guidance and teaching.
- Promote professional practice among radiology and breast services team members.
- Participate in quality monitoring and evaluation activities to ensure quality standards are maintained.
- Assist with breast biopsy ultrasound procedures.
- Complete all required data entry in Ikonopedia.
- Complete chart preparation prior to scheduled patient appointments.
- Prepare breast conference cases for radiologist review.
- Ensure imaging equipment is operating optimally by performing quality control testing and adjustments as needed.
- Obtain required continuing education and certifications necessary to maintain ultrasound technologist requirements.
- Maintain American College of Radiology accreditation requirements every three years.
- Coordinate patient care and department communications among radiology and breast services team members.
- Participate in departmental committees, meetings, and group activities as assigned.
- Maintain inventory of supplies, medications, and expendable materials.
- Demonstrate knowledge and competent operation of the McKesson Picture Archiving and Communication System within the scope of the position.
- Graduate of a Commission on Accreditation of Allied Health Education Programs or CMA-approved ultrasound or vascular technology education program.
- Certification and registration as a Radiologic Technologist through the American Registry of Radiologic Technologists.
West Cancer Center provides comprehensive cancer care with access to Phase I–III clinical trials through a partnership with Methodist Healthcare and the University of Tennessee Health Science Center. Patients receive standard cancer care and may enroll in trials, while clinicians and researchers collaborate across the lab and clinic to develop and apply new therapies. This collaboration gives patients early trial access and a lab-to-clinic workflow that ties research directly to treatment. The goal is to improve cancer outcomes by speeding up research and turning findings into effective, evidence-based therapies for patients.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Brighton, Colorado
Founded
1979
Get referred to West Cancer Center
See people who can refer or advise you
Simplify's Take
What believers are saying
- May 4, 2026 Bartlett opening expands surgical access and should drive new patient volume.
- April 2026 Atlas launch embeds value-based care teams beside West's oncologists.
- West's trial pipeline and 2026 conference reinforce recruiting, research prestige, and physician loyalty.
What critics are saying
- 2022 DOJ case against Methodist ties West to anti-kickback allegations and reputational spillover.
- West still depends on Methodist and UTHSC partnerships for referrals, trials, and credibility.
- A concentrated Memphis footprint leaves West vulnerable if local competitors capture oncology growth.
What makes West Cancer Center unique
- West Cancer Center operates 11 campuses across Memphis and West Tennessee.
- April 7, 2026 partnerships with IDEOlogy Health deepen provider education and clinical integration.
- July 28, 2026 ChoICE trial made West the first U.S. ProSense cryoablation site.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Company News
Advancing breast cancer care with cryoablation therapy. Jul 28th, 2026 West Cancer Center is so proud to announce the launch of a groundbreaking clinical study with IceCure Medical, making its network the 1st U.S. clinical site for the company's ProSense(R) cryoablation technology. The ChoICE Study will evaluate the use of ProSense(R) cryoablation in low-risk breast cancer patients, enrolling approximately 400 patients across 30 clinical sites nationwide. This important research will help gather real-world data and advance the use of innovative, minimally invasive treatment options for eligible patients. This technology, which has received FDA approval for use in patients age 70 and older with low-risk breast cancer, offers a potential alternative to traditional surgical treatment by using a minimally invasive approach designed with patient experience in mind. The study within its network will be led by Dr. Richard Gilmore, breast surgical oncologist, whose expertise and leadership will help advance research focused on improving breast cancer treatment options. At West, West Cancer Center remain committed to bringing innovative therapies and clinical research opportunities to its patients while continuing to redefine what is possible in cancer care.
West Cancer Center news briefs. May 04, 2026 at 02:55 pm by pjeter West Cancer Center & Research Institute is pleased to announce that Dr. Allison Vaughn Jones has joined their Dermatology Multidisciplinary Clinic. Jones is a highly respected, board certified dermatologist at UT Dermatology and brings extensive experience in diagnosing and managing complex skin conditions, including those that intersect with oncology care. She will be collaborating with Dr. Jason Chandler and Dr. David Portnoy to enhance coordinated care for patients with skin cancers, treatment related dermatologic concerns, and other conditions that benefit from integrated expertise. This is a collaboration between West Cancer Center and Research Institute and the University of Tennessee Health Science Center. Jones will continue her practice at UT as the Assistant Professor of Dermatology at UTHSC, while collaborating with Dr. Portnoy. West Cancer Center & Research Institute has opened a new clinic location in Bartlett. This expansion reflects their continued commitment to increasing access to high-quality cancer care across the Mid-South. The Bartlett office will operate Monday through Thursday and will initially function as a surgery clinic. The following specialists will be providing services at the Bartlett location. Head & Neck Oncology - Dr. Richard Muller Breast Surgical Oncology - Dr. Linda Han Gynecologic Oncology - Dr. Todd Tillmanns Urogynecology - Dr. Ben Abdu Dr. Axel Grothey, medical oncologist and Director of Gastrointestinal Cancer Research at West Cancer Center & Research Institute, recently authored a powerful column in The Tennessean highlighting the urgent need for colorectal cancer screening across Tennessee. Grothey sheds light on the state's high rates of colon cancer diagnoses and deaths, while emphasizing that early detection can dramatically improve outcomes. His column also introduces a promising new FDA-approved blood test - the Shield test - which offers a more convenient, non-invasive screening option for eligible adults. Through his perspective, Grothey reinforces a critical message: one conversation with a doctor and one screening test can truly save lives. A new study published in Nature Publishing Group highlights promising strategies to improve adherence to oral endocrine therapy (AET) among younger breast cancer patients - an area critical to long-term outcomes. Dr. Gregory Vidal co-authored this important research, which examined the impact of app-based remote monitoring on treatment adherence. Findings from this randomized trial demonstrated that premenopausal women using a remote symptom-monitoring app achieved significantly higher 12-month adherence rates compared to usual care (53.9 percent vs. 25.0 percent), while no significant benefit was observed among postmenopausal patients. These results underscore the unique challenges younger patients face and highlight remote monitoring as a scalable, technology-driven approach to help close adherence gaps and improve outcomes. Link: https://www.nature.com/articles/s41523-026-00900-9
West Cancer Center and IDEOlogy Health announce strategic partnership to advance patient-centered oncology education and care. PR Newswire Today at 7:42am PDT MEMPHIS, Tenn. and AUSTIN, Texas, April 7, 2026 /PRNewswire/ - West Cancer Center & Research Institute, the Mid-South's premier provider of comprehensive adult cancer care, and IDEOlogy Health, a leader in delivering non-promotional, multi-channel medical education to oncology professionals, today announced two exclusive strategic partnership agreements designed to elevate physician and Advanced Practice Provider (APP) education. Together, these collaborations aim to strengthen oncology care delivery and improve outcomes for patients across the community. With more than 46 years of oncology expertise, 113 specialized providers, and care provided to more than 68,000 patients annually, West Cancer Center & Research Institute is a nationally recognized model for integrated cancer care. West offers advanced treatments, innovative therapies, and comprehensive patient support services, all grounded in research-driven and compassionate care. IDEOlogy Health is widely recognized for its commitment to "Creating Aha! Moments in Healthcare(R)" and for leading innovation in how healthcare professionals stay current with advancements in medicine. Through expert-led programs, roundtable discussions, and real-time clinical data updates, IDEOlogy Health empowers oncology providers with timely, relevant insights that can impact patient care from day one. A Shared Commitment to Patients This partnership reflects a shared vision between West Cancer Center & Research Institute and IDEOlogy Health: to enhance the patient journey by equipping oncology care teams with high-quality clinical education and practical tools that support exceptional, holistic care. "Our partnership with IDEOlogy Health reflects West Cancer Center & Research Institute's continued commitment to leading the region in advanced, evidence-based oncology care," said Sylvia Richey, MD, Medical Oncologist and Chief Medical Officer for West. "By expanding access to the latest clinical insights and high-quality educational resources, we are strengthening the expertise of our physicians and advanced practice providers. This collaboration further enhances our ability to deliver exceptional, patient centered care across every community we serve." By combining IDEOlogy Health's innovative educational platforms with West's deep clinical expertise, the collaboration will help accelerate the integration of emerging research into everyday clinical practice, ensuring patients benefit from the latest scientific advancements, regardless of where they receive care. "We're thrilled to partner with West Cancer Center to deliver a multi-channel medical education program tailored to the needs of its physicians and advanced practice providers," said Cameron Lush, President of IDEOlogy Health. "This partnership helps ensure care teams have timely access to the latest clinical insights to support the best possible outcomes for patients." About West Cancer Center & Research Institute West Cancer Center & Research Institute is a nationally recognized leader in adult cancer care, offering comprehensive oncology services across multiple locations in the Mid-South. With a mission rooted in research, advanced treatments, prevention, and equitable access to care, West's multidisciplinary team delivers exceptional support to patients and families throughout the entire cancer journey. About IDEOlogy Health IDEOlogy Health, part of The Lockwood Group, is leading the change in how healthcare professionals connect and stay up to date on the latest advancements in medicine. The company leverages decades of healthcare expertise and emerging technology to provide data, analysis, and educational opportunities from experts across the globe in therapeutic areas of Oncology and Hematology. SOURCE IDEOlogy Health This is a paid placement. For further inquiries, please contact PR Newswire directly.
Atlas Oncology Partners, a value-based cancer care company, has officially launched in Memphis, Tennessee, with its first partner, West Cancer Center & Research Institute. The company aims to enhance existing cancer care by embedding support teams within partner practices to guide patients through all phases of treatment. Atlas offers whole-person care coordination, psychosocial support, and management of cancer-adjacent conditions. The company's model includes onsite and virtual care teams working alongside oncologists whilst assuming full medical cost risk. Founded by President Kate Roberts and Chief Medical Officer Dr Gabrielle Rocque, Atlas plans to expand throughout the Southeast in 2026, targeting markets in Alabama, Arkansas, Louisiana, Mississippi and Texas. The company remains in pre-revenue stage whilst establishing its partnership model.
The oncologist with West Cancer Center has been named one of the 2024 Top Doctors in Memphis by the Castle Connolly research group.